<?xml version="1.0" encoding="UTF-8"?>
<communities type="array">
  <community>
    <causes></causes>
    <created-at type="datetime">2009-05-27T13:20:20+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Atrophoderma of Pasini and Pierini is a form of dermal atrophy.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Atrophoderma of Pasini and Pierini is a form of dermal atrophy.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1391</id>
    <name>Idiopathic Atrophoderma of Pasini and Pierini</name>
    <participations-count type="integer">1</participations-count>
    <permalink>idiopathic-atrophoderma-of-pasini-and-pierini</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>IAPP</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-05-27T13:20:20+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-12-31T03:39:40+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Autoimmune Hemolytic Anemia is a reduction in the number of red blood cells due to  the body&amp;#8217;s immune system.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Autoimmune Hemolytic Anemia is a reduction in the number of red blood cells due to  the body&amp;#8217;s immune system.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1302</id>
    <name>Idiopathic Autoimmune Hemolytic Anemia</name>
    <participations-count type="integer">1</participations-count>
    <permalink>idiopathic-autoimmune-hemolytic-anemia</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Idiopathic Autoimmune Hemolytic Anaemia </synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-02-26T14:46:18+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:33+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Hypersomnia is a rare sleep disorder characterized by daytime sleepiness.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Hypersomnia is a rare sleep disorder characterized by daytime sleepiness.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">740</id>
    <name>Idiopathic Hypersomnia</name>
    <participations-count type="integer">3</participations-count>
    <permalink>idiopathic-hypersomnia</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">4.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2008-11-23T14:08:29+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:32+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Pulmonary Fibrosis is a rare pulmonary disorder characterized by scarring of the lungs.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Pulmonary Fibrosis is a rare pulmonary disorder characterized by scarring of the lungs.&lt;/p&gt;</disorder-description>
    <expert-id type="integer">2045</expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">554</id>
    <name>Idiopathic Pulmonary Fibrosis</name>
    <participations-count type="integer">6</participations-count>
    <permalink>idiopathic-pulmonary-fibrosis</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">27.0</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>IPF, Cryptogenic Fibrosing Alveolitis</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2009-04-22T17:30:06+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2010-01-04T15:39:55+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Pulmonary Haemosiderosis is a rare lung disorder characterized by alveolar capillary bleeding and accumulation of iron (in the form of haemosiderin) in the lungs.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Pulmonary Haemosiderosis is a rare lung disorder characterized by alveolar capillary bleeding and accumulation of iron (in the form of haemosiderin) in the lungs.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1459</id>
    <name>Idiopathic Pulmonary Haemosiderosis</name>
    <participations-count type="integer">1</participations-count>
    <permalink>idiopathic-pulmonary-haemosiderosis</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>IPH</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2010-01-04T15:39:55+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-12-26T15:50:41+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Sensory Polyneuropathy is a disorder affecting the nerves that has no identifiable primary cause.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Sensory Polyneuropathy is a disorder affecting the nerves that has no identifiable primary cause.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1289</id>
    <name>Idiopathic Sensory Polyneuropathy</name>
    <participations-count type="integer">1</participations-count>
    <permalink>idiopathic-sensory-polyneuropathy</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-12-26T15:50:41+00:00</updated-at>
  </community>
  <community>
    <causes>&lt;p&gt;In children, &lt;span class="caps"&gt;ITP&lt;/span&gt; is often preceded by a virus. In adults, cause is unknown.&lt;/p&gt;</causes>
    <created-at type="datetime">2008-05-23T23:41:13+00:00</created-at>
    <description>&lt;p&gt;Idiopathic Thrombocytopenic Purpura is a condition in which the blood does not clot as quickly as it should due to a low number of platelets.&lt;/p&gt;</description>
    <diagnosis>&lt;p&gt;Diagnosis is one of exclusion. When platelet counts are less than 100,000, other causes of low platelets are examined, and if none exist, then the diagnosis is Idiopathic (or immune) Thrombocytopenic Purpura.&lt;/p&gt;</diagnosis>
    <disorder-description>&lt;p&gt;Idiopathic Thrombocytopenic Purpura is a condition in which the blood does not clot as quickly as it should due to a low number of platelets. This may result in bleeding problems.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms>&lt;p&gt;Bruising, prolonged bleeding and nosebleeds.&lt;/p&gt;
&lt;p&gt;Many patients complain of fatigue when counts are low, to the point where &lt;span class="caps"&gt;ITP&lt;/span&gt; specialists believe their must be a connection to &lt;span class="caps"&gt;ITP&lt;/span&gt;, but there is no explanation for that connection.&lt;/p&gt;</general-symptoms>
    <general-test>&lt;p&gt;&lt;span class="caps"&gt;CBC&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Bone Marrow Biopsy (in older patients or patients considering splenectomy as a treatment option)&lt;/p&gt;</general-test>
    <general-treatment>&lt;p&gt;Corticosteroids&lt;br /&gt;
Anti-D&lt;br /&gt;
Anti CD20 (Rituximab)&lt;br /&gt;
Splenectomy&lt;/p&gt;
&lt;p&gt;In clinical trials at the moment and close to availability: &lt;span class="caps"&gt;TPO&lt;/span&gt; Agonists that increase platelet production.&lt;/p&gt;</general-treatment>
    <id type="integer">1059</id>
    <name>Idiopathic Thrombocytopenic Purpura</name>
    <participations-count type="integer">10</participations-count>
    <permalink>idiopathic-thrombocytopenic-purpura</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis>&lt;p&gt;80% of Children have &amp;#8220;acute&amp;#8221; cases which resolve within 6-12 months.&lt;/p&gt;
&lt;p&gt;20% of Adults seem to have &amp;#8220;acute&amp;#8221; cases, 80% are considered chronic, but many of those do not require treatment.&lt;/p&gt;</prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Immune Thrombocytopenic Purpura, ITP,  Autoimmune Thrombocytopenic Purpura, ATP, TTP, Moschcowitz disease, Idiopathic thrombotic thrombocytopenic purpura, Idiopathic TTP, thrombotic thrombocytopenic purpura</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">1</topics-count>
    <updated-at type="datetime">2009-02-11T13:46:37+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-12-25T05:46:06+00:00</created-at>
    <description>&lt;p&gt;IgA Nephropathy is a kidney disease that occurs when the antibody IgA lodges in your kidneys.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;IgA Nephropathy is a kidney disease that occurs when the antibody IgA lodges in your kidneys.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1285</id>
    <name>IgA Nephropathy </name>
    <participations-count type="integer">3</participations-count>
    <permalink>iga-nephropathy</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Berger's Disease, Berger Disease, IgAN</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-12-25T05:46:06+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:33+00:00</created-at>
    <description></description>
    <diagnosis></diagnosis>
    <disorder-description></disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">674</id>
    <name>Iminoglycinuria</name>
    <participations-count type="integer">0</participations-count>
    <permalink>iminoglycinuria</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">6.68</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>familial iminoglycinuria</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-07-02T18:35:27+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:34+00:00</created-at>
    <description>&lt;p&gt;Inclusion Body Myositis is a rare inflammatory muscle disease.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Inclusion Body Myositis is a rare inflammatory muscle disease.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms>&lt;p&gt;Muscle Weakness&lt;/p&gt;</general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">927</id>
    <name>Inclusion Body Myositis</name>
    <participations-count type="integer">3</participations-count>
    <permalink>inclusion-body-myositis</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">0.49</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>IBM, Sporadic Inclusion Body Myositis, sIBM,</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-08-27T19:48:29+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-05-21T13:25:35+00:00</created-at>
    <description>&lt;p&gt;Incontinentia Pigmenti is a genetic disorder that affects the skin, hair, teeth, and nails.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Incontinentia Pigmenti is a genetic disorder that affects the skin, hair, teeth, and nails.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">980</id>
    <name>Incontinentia Pigmenti</name>
    <participations-count type="integer">1</participations-count>
    <permalink>incontinentia-pigmenti</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal">0.2</prevalence-number>
    <prevalence-number-source-url>http://www.orpha.net</prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Bloch-Sulzberger disease, Bloch Siemens syndrome, melanoblastosis cutis, naevus pigmentosus systematicus
</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-12-11T14:15:46+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-07-04T05:34:26+00:00</created-at>
    <description>&lt;p&gt;Intestinal Pseudo Obstruction is a rare disorder characterized by the decreased ability of the intestines to push food through.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Intestinal Pseudo Obstruction is a rare disorder characterized by the decreased ability of the intestines to push food through.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1125</id>
    <name>Intestinal Pseudo Obstruction</name>
    <participations-count type="integer">0</participations-count>
    <permalink>intestinal-pseudo-obstruction</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Intestinal pseudoobstruction, Ogilvie syndrome</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-07-04T05:35:41+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-12-26T15:03:50+00:00</created-at>
    <description>&lt;p&gt;Intracranial Lipomas are rare congenital malformations, usually pericallosal asymptomatic midline lesions.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Intracranial Lipomas are rare congenital malformations, usually pericallosal asymptomatic midline lesions.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1286</id>
    <name>Intracranial Lipoma </name>
    <participations-count type="integer">1</participations-count>
    <permalink>intracranial-lipoma</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-12-26T15:05:13+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-07-05T16:20:12+00:00</created-at>
    <description>&lt;p&gt;Iritis is characterized by the inflammation of the iris of the eye.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Iritis is characterized by the inflammation of the iris of the eye. There are two types of iritis, acute and chronic.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms></general-symptoms>
    <general-test></general-test>
    <general-treatment></general-treatment>
    <id type="integer">1129</id>
    <name>Iritis</name>
    <participations-count type="integer">4</participations-count>
    <permalink>iritis</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags></synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2008-07-05T16:20:12+00:00</updated-at>
  </community>
  <community>
    <causes></causes>
    <created-at type="datetime">2008-09-22T01:39:39+00:00</created-at>
    <description>&lt;p&gt;Isaac&amp;#8217;s Syndrome is a rare neuromuscular disorder.&lt;/p&gt;</description>
    <diagnosis></diagnosis>
    <disorder-description>&lt;p&gt;Isaac&amp;#8217;s Syndrome is a rare neuromuscular disorder.&lt;/p&gt;</disorder-description>
    <expert-id type="integer" nil="true"></expert-id>
    <general-symptoms>&lt;p&gt;There are several symptoms that affect patients with Isaac&amp;#8217;s Syndrome.&lt;/p&gt;</general-symptoms>
    <general-test></general-test>
    <general-treatment>&lt;p&gt;There is no cure for Isaac&amp;#8217;s Syndrome.&lt;/p&gt;</general-treatment>
    <id type="integer">1207</id>
    <name>Isaac's Syndrome</name>
    <participations-count type="integer">3</participations-count>
    <permalink>isaac-s-syndrome</permalink>
    <posts-count type="integer">0</posts-count>
    <prevalence-number type="decimal" nil="true"></prevalence-number>
    <prevalence-number-source-url></prevalence-number-source-url>
    <prevalence-type>Per 100,000 Population</prevalence-type>
    <prognosis></prognosis>
    <symptoms-count type="integer" nil="true"></symptoms-count>
    <synonym-tags>Neuromyotonia, Isaac-Mertens Syndrome, Continuous Muscle Fiber Activity Syndrome, Quantal Squander Syndrome, Isaacs Syndrome</synonym-tags>
    <synonyms-count type="integer">0</synonyms-count>
    <topics-count type="integer">0</topics-count>
    <updated-at type="datetime">2009-11-03T19:07:47+00:00</updated-at>
  </community>
</communities>
